Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06000527

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Imagine Institute · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.

Detailed description

Recurrent respiratory papillomatosis (RRP) is characterized by the recurrent proliferation of multiple polypoid squamous tumors in the respiratory tract, linked to HPV infection. RRP is a rare disease. However, it is the most common benign laryngeal tumor in children. There are currently no French national epidemiological data on this disease. The data collected by the reference centers will enable us to gain a better understanding of this pathology in terms of epidemiology, risk factors, genetic susceptibility and clinical manifestations, as well as to significantly study the efficacy of the various existing therapies and preventive measures, in order to establish a clear, standardized and optimal guideline.

Conditions

Timeline

Start date
2022-10-01
Primary completion
2032-09-30
Completion
2032-09-30
First posted
2023-08-21
Last updated
2023-08-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06000527. Inclusion in this directory is not an endorsement.

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA " (NCT06000527) · Clinical Trials Directory